- Investigator
- David R Nelson
- Status
- Accepting Candidates
Research at a glance
Top areas of exploration
- Antiviral Agents , 59 publications
- Hepatitis C, Chronic , 53 publications
- Drug Therapy, Combination , 35 publications
- Hepatitis C , 31 publications
Research activity
Active clinical trials
My publications
Filter publications
237 publications
2022
Evaluation of machine learning algorithms for predicting direct-acting antiviral treatment failure among patients with chronic hepatitis C infection.
Scientific reports
PubMed • Publisher's site2022
Machine learning algorithms for predicting direct‐acting antiviral treatment failure in chronic hepatitis C: An HCV‐TARGET analysis
Hepatology
PubMed • Publisher's site2022
Predictors of 30-day readmission and hospitalization costs of patients with hepatic encephalopathy in the US from 2010 to 2014.
Expert review of pharmacoeconomics & outcomes research
PubMed • Publisher's site2022
Sustainable and equivalent improvements in symptoms and functional well-being following viral cure from ledipasvir/sofosbuvir versus elbasvir/grazoprevir for chronic hepatitis C infection: Findings from the randomized PRIORITIZE trial.
Journal of viral hepatitis
PubMed • Publisher's site2021
A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study.
Hepatology (Baltimore, Md.)
PubMed • Publisher's site